Triamcinolone, Bevacizumab Yield Similar VA Outcomes In Cataract Patients With DME

Ocular Surgery News

SAN DIEGO — No significant difference in best corrected visual acuity was seen when patients with diabetic macular edema at the time of cataract surgery were given either triamcinolone or bevacizumab, according to a speaker here.

  • <<
  • >>

Comments